This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Ketorolac Tromethamine Injection, USP (2015-06-30)

Starting date:
June 30, 2015
Posting date:
July 7, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-54124

Recalled Products

Ketorolac Tromethamine Injection, USP

Reason

Potential for presence of particulate matter in the glass vials containing Ketorolac.

Depth of distribution

Wholesalers and Hospitals

Affected products

Ketorolac Tromethamine Injection, USP

DIN, NPN, DIN-HIM
DIN 02390582
Dosage form

Solution

Strength

Ketorolac Tromethamine 30 mg / mL

Lot or serial number
  • 41526DK
Companies
Recalling Firm
Hospira Healthcare Corporation
2600 Boul. Alfred-Nobel, Suite 100
St Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
2600 Boul. Alfred-Nobel, Suite 100
St Laurent
H4S 0A9
Quebec
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: